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Hereditary benign intraepithelial dyskeratosis (HBID) is an autosomal dominant disorder characterized by elevated
epithelial plaques on the ocular and oral mucous membranes. It has been reported primarily, but not exclusively,
in individuals of American Indian heritage in North Carolina. We have examined and obtained DNA on two large
families affected by HBID. Using genetic linkage analysis we have localized the HBID gene to chromosome 4 (4q35)
with a peak LOD score of 8.97. Molecular analysis of these data reveals that all individuals affected with HBID
in both families demonstrate the presence of three alleles for two tightly linked markers, D4S1652 and D4S2390,
which map to the telomeric region of 4q35. This suggests the presence of a duplication segregating with the disease
phenotype that is most likely involved in its causation.
Von Sallmann and Paton first described autosomal dom-
inant hereditary benign intraepithelial dyskeratosis
(HBID [MIM 127600]) in 1959 (von Sallmann and Pa-
ton 1959). Several additional cases (Yanoff 1968; Shields
et al. 1987) have been subsequently reported, all but one
(McLean et al. 1981) trace their ancestry back to North
Carolina. The onset of HBID is usually at birth or in
early childhood. Lesions consist of elevated, granular,
white-to-grayish epithelial plaques located within the ex-
posed nasal and/or temporal conjunctival surface. The
growths can interfere with vision (von Sallmann and
Paton 1960), although this is uncommon. Occasionally,
the plaques can involve the cornea or can spontaneously
shed. The large plaques are frequently associated with
hyperemic blood vessels producing a “red eye” appear-
ance, which gives HBID this common colloquial name.
Affected individuals report that this “bloodshot” ap-
pearance has led many to experience difficulties in job
employment and social interactions, as strangers often
assume their appearance is a result of alcohol or drug
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abuse or is secondary to infection. The oral mucosa in
HBID has a white, spongy, macerated appearance and
may demonstrate pinpoint elevations when stretched.
Von Sallman and Paton (1960) first reported that the
disorder has an apparent seasonal interaction, becoming
much worse in the spring and summer and subsiding in
the cooler weather of the fall. Histologically, the epi-
thelium in HBID is markedly thickened by the pathog-
nomonic hyperplasia, hyperkeratosis, acanthosis, and
contains individual cell dyskeratoses. Although the oc-
ular and oral lesions associated with HBID can clinically
resemble malignant neoplasms, the condition does not
invade the underlying tissue and remains localized to the
sites of the primary lesions.
Two families (DUK 5800 and DUK 5801) were ascer-
tained through the Duke University Medical Center
(DUMC) Department of Ophthalmology. DUK 5800was
initially described by Witkop et al. (Witkop et al. 1960)
and later by Reed et al. (1979). A second family, DUK
5801, living in a neighboring county, was ascertained in-
dependently. After informed consent was obtained from
all family members, individuals were examined by a
board-certified ophthalmologist (R.R.A.). Clinical affec-
tion status was classified as follows: (1) “definite,” con-
junctival erythema in both eyes and plaque 12 mm
(greatest dimension) in each eye; (2) “probable,” con-
junctival erythema in both eyes and plaque 12mm in only
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Figure 1 Segregation of the HBID duplication in three genera-
tions of the family DUK 5800. Affected individuals have blackened
symbols.
a single eye; (3) “unknown,” conjunctival erythema, with
or without plaque in either eye, or status not possible to
determine by clinical examination; and (4) “normal,” no
conjunctival abnormality.
Blood was obtained by venipuncture, and DNA was
extracted using conventional methods (Ben Othmane et
al. 1999). Genotyping was performed using the fluores-
cent allele static scanning technique (FASST) developed
at the DUMCCenter for HumanGenetics (CHG) (Vance
and Ben Othmane 1997). Radiation-hybrid scoring at
the Whitehead Institute Web site was done using PCR
on the GB4 hybrid panel for D4S1652 and D4S2390.
Markers were run in duplicate.
All family-history, clinical, and genotyping data were
maintained in the PEDIGENE database system (Haynes
et al. 1995). Two-point and multipoint linkage analyses
were performed using the Vitesse software package
(O’Connell and Weeks 1995). The model linkage as-
sumed autosomal dominant inheritance with a disease-
allele frequency of .01. Estimation of the penetrance
function was done by maximizing the log-likelihood
with respect to the penetrance parameter (Speer 1998).
Full penetrance was used for individuals classified as
“definite” and 90% penetrance for individuals classified
as “probable.” A 10% phenocopy rate was also included
in the model for all susceptible individuals.
In addition, an “affecteds only” or low-penetrance
model was performed, in which the disease phenotypes
for at-risk family members were excluded while the
marker genotypes of all family members were retained
to maximize information on linkage phase. Markers
were chosen from the Marshfield and Ge´ne´thon ge-
netic maps (D4S408–8 cM–D4S3332–4 cM–[D4S2283–
0.0 cM–D4S187–0.0 cM–D4S2688–0.0 cM–D4S2930–
0.0 cM–D4S1652–0.0 cM–D4S2390]–4 cM–D4S1523).
Marker allele frequencies were generated from 38 un-
related American Indians living in the same general ge-
ographical region.
The two large families affected by HBID (DUK 5800
and 5801), according to genealogical data and self-report
by family members, were not known to be related. Of 55
individuals studied, 25 were affected. Only two individ-
uals met the classification of “probable.” Before evidence
of linkage was found, 97 polymorphic markers were
screened. A maximum combined LOD score of 7.32 was
obtained at maximum recombination fraction ( ) .00 be-ˆv
tween the disease locus and marker locus D4S1652, lo-
cated on chromosome 4q35. Low-penetrance analysis
confirmed these findings: at (data notˆˆ(z)p 6.10 vp .00
shown). Subsequently, the families were genotyped with
the surrounding markers D4S408, D4S3332, D4S2283,
D4S18, D4S2688, D4S2930, and D4S1523. D4S1523
gave the highest score, with at . Low-ˆˆ(z)p 8.97 vp .00
penetrance analysis of these data gave similar, although
slightly less significant, LOD scores supporting the full-
pedigree analysis of the data (data not shown).Multipoint
analysis of the markers (D4S3332, D4S1652, D4S2390,
and D4S1523) resulted in a peak LOD score of 11.58 at
the D4S2390 (data not shown). Similar results were ob-
tained when D4S1652 was substituted into themultipoint
analysis for D4S2390.
Examination of the marker data showed that two
markers, D4S1652 and D4S2390, demonstrated three al-
leles in multiple affected individuals in both families.
These markers are independent loci, with a GATA repeat
as one marker and an ATA repeat comprising the other.
The segregation of one of the markers in a portion of
family DUK 5800 is shown in figure 1. Affected individ-
uals not displaying three alleles received a copy of one of
the two duplicated alleles from their unaffected parent
(fig. 1). Since these individuals were homozygous for one
of the two duplicated alleles, three alleles were not ob-
served upon genotyping. Thus, these data are compatible
with the segregation of a duplicated haplotype in the fam-
ily. Haplotype analysis reveals that both families showed
consistent segregation of the duplication and shared the
same duplicated haplotype. Even though it was not pos-
sible to establish a documented link between the two fam-
ilies, the sharing of an identical duplicated haplotype
strongly suggests that, as expected, they are derived from
the same ancestral founder. The sizes, in base pairs, of
the duplicated microsatellite haplotypes in both families
are 150/142 for D4S1652 and 111/102 for D4S2390. For
the linkage analysis, these duplicated haplotypes were run
as a single, unique allele. To map the extent of the du-
plication, additional markers that were closely linked to
D4D1652 and D4S2390 (D4S408, D4S2283, D4S187,
D4S2688, D4S2930, D4S2299, and D4S1523) were also
examined for evidence of duplication, but no individ-
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uals with three alleles were found for these markers. Also,
three alleles for D4S2390 and D4S1652 were not found
in any of the married-in or control samples. No parent-
of-origin effects were seen in the segregation of the dupli-
cation. Radiation-hybrid screening demonstrated that
D4S1652 and D4S2390 lie ∼6.4 cR3000 apart. This sug-
gests a physical distance of ∼1.7 Mb between D4S2390
and D4S1652.
The finding of three alleles segregating for the two
markers D4S1652 and D4S2390 is very similar to the
initial reports in the Charcot-Marie-Tooth disorder type
1 (CMT1A) (Couch et al. 1991; Raeymaekers et al. 1991)
duplication. Whether the HBID duplication leads to sim-
ilar regulatory abnormalities as seen in CMT1A (Tim-
merman et al. 1992) or causes a gene disruption has yet
to be determined.
The most intriguing candidate gene in the region of
the duplication is the human homolog of the FAT gene,
an epithelial gene which can promote abnormal epithe-
lial cell proliferation and functions as a tumor suppressor
in Drosophila (Mahoney et al. 1991; Gray 1992; Dunne
et al. 1995). This presents with a phenotype somewhat
similar to HBID. This very large gene (15 kb) is thought
to function in mammalian cell communication. This
gene lies ∼7.4 cR (2.0 Mb) from D4S1652 on the Gene-
map 99 radiation-hybrid map.
In summary, we have localized the HBID gene to chro-
mosome 4q35. Analysis has found a duplication segre-
gating in the affected individuals that appears to lead to
the abnormal cell proliferation in HBID patients.
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